Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Inhaled Iloprost for the Prevention of Lung Cancer in Former Smokers

NCT02237183 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02237183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02237183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Inhaled Iloprost for the Prevention of Lung Cancer in Former Smokers
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
November 5, 2015
Completion date
August 30, 2023
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung carcinoma